{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Matos L"],"funding":["Associazione Italiana di Oncologia Medica","Instituto de Salud Carlos III"],"pagination":["104558"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12683136"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["84"],"pubmed_abstract":["<h4>Background</h4>Routine brain imaging screening (BIS) in patients with metastatic breast cancer (BC) without neurological symptoms is currently not recommended, as no survival/quality-of-life improvements have been demonstrated. We aimed to examine physicians and patients' attitudes and perceptions toward BIS.<h4>Methods</h4>International cross-sectional online survey for patients and physicians, distributed from May 2023 to February 2024. Patients with BC diagnosis were deemed eligible for patients' survey completion and BC-treating physicians were invited to fill the physicians' questionnaire.<h4>Results</h4>A total of 529 physicians from 50 countries (80 % European) responded, mostly medical oncologists (70 %) working in academic hospitals (53 %). Most physicians request BIS (65 %), "],"journal":["Breast (Edinburgh, Scotland)"],"pubmed_title":["Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives."],"pmcid":["PMC12683136"],"funding_grant_id":["JR24/00024"],"pubmed_authors":["le Du F","Morgan G","Haidinger R","Rodriguez Recio G","Muller V","Criscitiello C","Brucker S","Laakmann E","Matos L","Fontes Sousa M","Schettini F","Jerzak KJ","Dieras V","Lambertini M","von Kroge P","Braga S","Schumacher-Wulf E","Linn S","van Ramshorst M","Agostinetto E"],"additional_accession":[]},"is_claimable":false,"name":"Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives.","description":"<h4>Background</h4>Routine brain imaging screening (BIS) in patients with metastatic breast cancer (BC) without neurological symptoms is currently not recommended, as no survival/quality-of-life improvements have been demonstrated. We aimed to examine physicians and patients' attitudes and perceptions toward BIS.<h4>Methods</h4>International cross-sectional online survey for patients and physicians, distributed from May 2023 to February 2024. Patients with BC diagnosis were deemed eligible for patients' survey completion and BC-treating physicians were invited to fill the physicians' questionnaire.<h4>Results</h4>A total of 529 physicians from 50 countries (80 % European) responded, mostly medical oncologists (70 %) working in academic hospitals (53 %). Most physicians request BIS (65 %), ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-06-06T00:16:08.396Z","creation":"2026-05-23T03:13:58.857Z"},"accession":"S-EPMC12683136","cross_references":{"pubmed":["40849221"],"doi":["10.1016/j.breast.2025.104558"]}}